fluoxetine has been researched along with (R)-fluoxetine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuller, RW; Krushinski, JH; Leander, JD; Robertson, DW | 1 |
Cyriac, G; Javitch, JA; Katz, JL; Kopajtic, T; Newman, AH; Zhang, P; Zhao, Y | 1 |
Cortizo, L; García, N; Innerárity, A; Labeaga, L; Mosquera, R; Orjales, A; Pumar, MC; Toledo, A | 1 |
3 other study(ies) available for fluoxetine and (R)-fluoxetine
Article | Year |
---|---|
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.
Topics: Analgesia; Animals; Brain; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Drinking; Drug Synergism; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Conformation; Morphine; p-Chloroamphetamine; Pain Measurement; Propylamines; Rats; Serotonin; Stereoisomerism; Structure-Activity Relationship | 1988 |
Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transporters.
Topics: Amino Acid Transport Systems; Animals; Bacterial Proteins; Binding, Competitive; Brain; Citalopram; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Leucine; Ligands; Models, Molecular; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Radioligand Assay; Rats; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2010 |
Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain; Carrier Proteins; Fluoxetine; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Reboxetine; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship; Symporters | 2003 |